A comparison of polymerase chain reaction and an infectivity assay for human immunodeficiency virus type 1 titration during virus inactivation of blood components
暂无分享,去创建一个
P. Simmonds | F. Mcomish | P. Yap | H. Hart | W. Hart
[1] M. Busch,et al. Resolution of infection status of human immunodeficiency virus (HIV)‐ seroindeterminate donors and high‐risk seronegative individuals with polymerase chain reaction and virus culture: absence of persistent silent HIV type 1 infection in a high‐prevalence area , 1992, Transfusion.
[2] H. Watson,et al. Immunological abnormalities in haemophiliacs. , 1992, Blood reviews.
[3] H. Brackmann,et al. Absence of human immunodeficiency virus (HIV) proviral sequences in seronegative hemophilic men and sexual partners of HIV‐seropositive hemophiliacs , 1992, Transfusion.
[4] J. McKeating. Neutralization of virus. , 1992, Methods in molecular biology.
[5] A. Cuschieri,et al. Effect of fibrin glues on the mechanical properties of healing wounds , 1991, The British journal of surgery.
[6] P. Simmonds,et al. Detection, quantification and sequencing of HIV-1 from the plasma of seropositive individuals and from factor VIII concentrates. , 1991, AIDS.
[7] C. Loveday,et al. Detection of HIV-1 RNA in factor VIII concentrate. , 1991, AIDS.
[8] J. Moore,et al. Differential loss of envelope glycoprotein gp120 from virions of human immunodeficiency virus type 1 isolates: effects on infectivity and neutralization , 1991, Journal of virology.
[9] M. Collins. Practical molecular virology : viral vectors for gene expression , 1991 .
[10] EEC regulatory document. Note for guidance. Validation of virus removal and inactivation procedures. Committee for Proprietary Medicinal Products: Ad Hoc Working Party on Biotechnology/Pharmacy and Working Party on Safety Medicines. , 1991, Biologicals : journal of the International Association of Biological Standardization.
[11] P. Simmonds,et al. Hepatitis C quantification and sequencing in blood products, haemophiliacs, and drug users , 1990, The Lancet.
[12] P Balfe,et al. Analysis of sequence diversity in hypervariable regions of the external glycoprotein of human immunodeficiency virus type 1 , 1990 .
[13] Q. Sattentau,et al. Dissociation of gp120 from HIV-1 virions induced by soluble CD4. , 1990, Science.
[14] R. Tedder,et al. Detection of hepatitis C viral sequences in blood donations by "nested" polymerase chain reaction and prediction of infectivity , 1990, The Lancet.
[15] R. Tedder,et al. Detection by PCR of hepatitis C virus in factor VIII concentrates , 1990, The Lancet.
[16] R. Mcintosh,et al. The effect of solution formulation on the stability and surface interactions of factor VIII during plasma fractionation , 1990 .
[17] D. Evans,et al. Severely Heated Therapeutic Factor VIII Concentrate of High Specific Activity , 1989, Vox sanguinis.
[18] L. Winkelman,et al. Severe heat treatment of lyophilised coagulation factors. , 1989, Current studies in hematology and blood transfusion.
[19] A. Macleod,et al. Viral inactivation strategies for monoclonal antibodies: dry heating , 1989 .
[20] A. Dalgleish,et al. Quantitation of HIV-1 activity in tissue culture supernatants: effects of culture condition on syncytial assays and virus production. , 1989, Journal of virological methods.
[21] C. Prowse,et al. Studies on the effect of heat treatment on the thrombogenicity of factor IX concentrates in dogs , 1987, British journal of haematology.
[22] R. Mcintosh,et al. A HIGH-YIELD FACTOR VIII CONCENTRATE SUITABLE FOR ADVANCED HEAT TREATMENT , 1987, Thrombosis and Haemostasis.
[23] H. Geiger,et al. A strategy for testing established human plasma protein manufacturing procedures for their ability to inactivate or eliminate human immunodeficiency virus. , 1987, Journal of biological standardization.
[24] A. Prince,et al. EFFECT OF HEAT TREATMENT OF LYOPHILISED BLOOD DERIVATIVES ON INFECTIVITY OF HUMAN IMMUNODEFICIENY , 1986, The Lancet.
[25] M. Wiebe,et al. Inactivation of viruses in labile blood derivatives. I. Disruption of lipid‐enveloped viruses by tri(n‐butyl)phosphate detergent combinations , 1985, Transfusion.
[26] M. Wiebe,et al. Inactivation of viruses in labile blood derivatives. II. Physical methods , 1985, Transfusion.
[27] P. Mannucci,et al. TRANSMISSION OF NON-A, NON-B HEPATITIS BY HEAT-TREATED FACTOR VIII CONCENTRATE , 1985, The Lancet.
[28] S. Middleton,et al. A Therapeutic Concentrate of Coagulation Factors II, IX and X from Citrated, Factor VIII‐Depleted Plasma , 1973, Vox sanguinis.
[29] R. Hardisty,et al. A One-stage Factor VIII (Antihaemophilic Globulin) Assay and its Use on Venous and Capillary Plasma , 1962, Thrombosis and Haemostasis.